In North America, management of glaucoma includes observation, medical therapy, laser surgery, and ab-externa ocular surgery.[1] Although management of glaucoma in Russia does not differ greatly from that in the West, Russia has a unique biomaterial, Alloplant. Figure 1. (click image to zoom) Various Alloplant biomaterials for ophthalmic surgery. Courtesy of the Alloplant Web site: http://www.alloplant.ru/index2_eng.php?page=3&pagel2=3. This unique biomaterial has been documented in Russian literature not only to lower intraocular pressure (IOP) but also to have the potential to induce normal tissue regeneration (allowing for restoration of normal eye physiology), decrease inflammatory response, prevent or minimize scarring, and stimulate regeneration of natural host tissues.